Introduction: The medical treatment of retentio testis remalns controversial because of ineffectiveness and/or slde-effects FSH seems to influence the spontaneous descent of the testis: lurthermore 11 induces LH receptors. Therefore we perlormed a double-bllnd, placebo-controlled study to Investigate the effect of FSH with hCH (half the recommended WHO dose) versus hCG alone in retentio testis patients. Methods: 22 boys w~l h retenlio testis were investigated Retractile testis were excluded. Group A (n= 14, 4 bilat. 10 unilat. mean age 3 15 yrs) was treated with 150 IU FSH 2x/wk durlng 2 weeks followed by 150 IU FSH and 250 IU hCG 2x/wk lor another 4 weeks. Group B (n-8. 2 bilat, 6 unilat; mean age 3 3 yrs) was treated wlth 250 IU hCG 2x/wk for 6 weeks Test~cular positlon. volume and consistency as well as the awearence ot scrotum. IenQth of penis were determined at weeh 0. 2 4 . 6 an0 1 2 o y 7 inacpenaent ~nde;tqators Bcoa investtgaton cons slea of -h. FSn T and SHBG S~J C C P S S I~I~ flerrenl was cons aereu when the testis reached a mid or low scrota1 position at week 12. Results: In group A 6/18 testes descended successfully. In group B 5/10 testes descended successfully. Of the unsuccesslully treated patients 6 patients of group A and 4 of group B were operated. Of these pallents 618 testes of group A and 415 testes of group B showed anatomical abnormalit~es, which could explain the lack of hormonal response. There were no slgniflcant differences in hormonal parameters between the 2 groups. In both arouos no serious side effects were mentioned or observed Conclusions: 1. Half the rdcommended WHO dose of hCG is suHicient to reach successful descent in 50 % of treated patients with no serlous side-effects; thls response rate is In agreement wlth the Iilerature. 2. FSH does not seem to have an additional eHect on the success rate. 3. Most o l the unsuccessfully treated patients showed anatomlcal
A Jccham, U. Kuhnle, D . Knorr, a n d H P. Schwarz. University Children's Hospital. Division of Pediatric Endocrinology. D -8 0 0 0 Munich. G e r m a n y W o r l d w~d e , m a n y patlents w i t h congenital adrenal hyperplasia (CAH) h a v e already r e a c h e d adulthood, b u t reports o n t h e long-term outcome are still sparse. I n o u r clinic population of g r o w n -u p C A H patients over 1 6 y e a r s of age. 181.1 c m : n=40). T h e r e w a s n o significant difference b e t w e e n females a n d m a l e s in final height, expressed a s standard deviation score (SDS). However, final h e i g h t in both, females a n d m a l e s , w a s markedly l o w e r t h a n target height (p<0.0001). F o r e a c h gender, m e a s u r e d final height dld n o t differ b e t w e e n p a t i e n t s w i t h S L -C A H a n d t h o s e w i t h S V -C A H . Furthermore, y o u n g e r g r o w n -u p C A H patients w e r e n o t taller t h a n older patients. On a v e r a g e , t i m i n g of p u b e r t a l d e v e l o p m e n t w a s n o r m a l , although menstrual irregularities and d e c r e a s e d testicular volumes were c o m m o n . W e conclude that despite adequate treatment C A H patients d o n o t r e a c h their full height potential. We reDort the resuns of a wm~rehc.nsive. cross-sectional aualrty-of-life evaluatlon. All patents ot the Unwersn, c n ldrtii s H-.sp!lal ndtn tne d agnosts O;CA~ above 18 years ana ratsea as fema es were CorIt~ctca aoa 2 3 (n=44, 01 1h2 c ,gab e pat ents ,n=63j partclpatea ana were ccmparea to a malcrled healtnf wnlrol group Most of tne pat ents (48 9%, s~t l~r e o lrom tne s~rnple-v r 112 ng (sv.) CAn. 34% had the san-aasttno fsrr-I form ana 17 % tne 16lv-orlset 110 \form of CAH In 35% of tne Dal ents " . .
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genital virilizat~on was pronounced (Prader stage 3 or 4). in 61% the correction was a wmblnatlon of clltoral recession and vaginal rewnstruction. Wh~le patients were wmparable to controls in most soc~odemographic characteristics, a higher proportion of patients were llvlng alone 52% versus 37% and only 22% versus 38% of the control group had children (1 sv-. 3 sw-, 3 lo-CAH). The mean number of children, however, was 1.87 in bolt] groups
No major dllferences between groups were found in the quallty-of-life assessment which pertalned to physlcal state, psychological well-being, soclal integration and funct~onal capacity Pat~ents d~ffered from controls in reduced soclal competence and domlnace (esp sw-CAH) However, the major dilferences between the groups were apparent in the psychosexual ~d e n t~l~c a t~o n with patients reporting to feel less feminine. Psychological adaptallon was good In terms of hlgh perceived social support Overall, the patients expressed a good quallty-of-llfe both in the interflew and the quesl~onnaires wilh only few s~gn~f~cant dlHerences between the varlous cllnical forms of CAH and the controls However, the psychosexual identlflcation is st111 problemat~c (esp sw-CAH) and ments increased rnedlcal and psychological efforts.
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I d e n t i f i c a t i o n o f a d r e n o l e u k o d y s t r o p h y g e n e a n d f u t u r e t h e r a p y P. Aubourg . -lndividudls wiih A1 and G D with .i taryotypc including a Y chromosome have a substantial i~icrcascd risk of dcvcli~l~in!! germ cell lumours as adults. We have prrvlously rcporled a high frequency of c;tr~~i,i,n,.~-~n-s~tu (CIS) in children and adolcsccnts wilh these disordcrs o f s c~u a l dilfercn~~,~l!on, and n c hcrein update our cxpcricnce with a total o f 33 paticnls bciween 1 n l i~n l l~ .~nd 20 ycars of age at the time o f gonadcctomy or biopsy. 21 patisnts with eiihcr ron~plctc or incomplctc AI, and 12 patients with G D and 46,XY karyotype or 45,X/46,NY ~nos;ticism u,cre studled The lauer individuals had cilhcr fem;jlc phcnotypc. ;~n,big~i<,u\ or male citcrnrd gcnit.ilia. Thc gon.tdcctomy and biupsy specimens ucrc removed lot ~~rciphylactic reasons. and neither ul~rasound nor pcropcralivc euamin;~lion of Ihc gon;id\ ralsed suspicion of ; ! germ cell lumour. The tissue was f~xed in Stic\'c's or Cl~liind's fluid and analysed hy conventional microscopy. The diagnosis of CIS and gon;~dohl;i\t~~m;~ was madc on morphological crlicrid. 5 (24%) o f 21 piiilcnls u.tth A1 had CIS. anil 111~. prcinv;lrivc ncopl;!si;t was delcclcd i n patients with both c~~n l p l c t c and incomplutc A l 3 of 6 indi\~idu.tls with G D and ;I fcmi~lc phenolypc had gonadohl.!stom:t or CIS ~ncluding ;I 9 ).car old girl with 4B.XY G D , who add~tion;~lly ~;ILI ;!rc;lr with inmsivc ncopl,ts~.~. 2 o f 3 patient, wilh 45.X146,XY G D and ambiguous gcnil;~l~;~ had CIS. and CIS u,as found in 3 o f 6 m a l o with GD. Thus, n total o l 6 O B o f t h c patients u,~!h G D h.10 cilhcr CIS or goni~dobl;~stoma. S~ncc boll1 CIS and gonadoblailoma can be considered to be prcinvasivc lesions, we recommend gonadeclomy when the diagnosis o l A l and G D is m;~dc, provided a fcmsle gendcr has bccn decided I n pnucnth with G D and mnlc phcnt,typc, we suggest a biopsy at the lime of d~agnosis. I f CIS is dslccleil, cilhcr gi,n:ideclon~y or close surve~ll;!nce is ad\,is.ihlc. Il orchiilcctomy i , nol pcrforlncd. ; ! hirlpsy ;!llcr puhcrty is rec<~mrncnded.
